Case Studies from across the Catapults

Themes (Reset)
Themes (Reset)

Driving growth and prosperity across UK innovation

We form a crucial link in the UK’s rich innovation ecosystem – helping organisations to demonstrate and de-risk their innovation strategies and to build internal capability that attracts further investment, creates jobs, trade and sustainable prosperity.

We work across multiple sectors such as health, net zero, digitisation and are building partnerships that helping the UK to fight dementia and cancer, power electric vehicles,  deliver 5G, drive low-carbon technologies from home heating to wind energy, create opportunities from space orbit data, create systems and places that enhance quality of life and so much more.

Take a look at a few examples of how Catapults are making a difference.  
Catapults (Reset)
Catapults (Reset)
Cell and Gene Therapy
alt=
Case Study
Upskilling the UK to take full advantage of the potential of cell and gene therapies
Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world’s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.
Read more
Cell and Gene Therapy
Case Study
Upskilling the UK to take full advantage of the potential of cell and gene therapies
Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world’s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.
Read more
Cell and Gene Therapy
Case Study
Delivering safer advanced therapies, faster and at lower cost through technology and process innovation
At its core, Cell and Gene Therapy Catapult is an innovation and technology company. Its work with industry in the development of novel processes and analytical techniques for cell and gene therapy manufacture has supported significant investment into startup businesses as well as attracting international manufacturers such as Rentschler to invest in manufacturing in the UK.
Read more
Cell and Gene Therapy
Case Study
Establishing Stevenage as a global leader for cell and gene therapies
UK Government invested £72m in the Cell and Gene Therapy Catapult centre in Stevenage. This has led to the creation of one of the leading cell and gene therapy clusters globally and brought £1.5bn to the region through the 45 companies that are now investing there.
Read more